We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lucira Health’s Rapid Home COVID-19 Test Gets EUA
The FDA issued an Emergency Use Authorization (EUA) for Lucira Health’s rapid coronavirus test, the first one authorized for self-testing at home and priced at an affordable $50.
To View This Article:
Login
Subscribe To International Devices & Diagnostics Monitor